ArticleAmerican journal of cancer research2020

Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression.

Yu-Lin Liu et al.PubMed ↗Full text ↗

No numbers read from the abstract.